Clinical Trial Update: Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating camrelizumab with chemotherapy for recurrent or advanced cervical neuroendocrine carcinomas; status and detailed results are not provid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Carcinoma
• Cervical Neuroendocrine Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Lei Li | Conditions: Chemotherapy, Anti-pd-1 Antibody | Phase 2 | Status: UNKNOWN